1. Introduction {#sec1-toxins-09-00342}
===============

Colombia has the third highest biodiversity of snakes in the Americas \[[@B1-toxins-09-00342]\]. In 2015, there were 4273 clinically confirmed cases of snakebite in the country, with an average of 82.2 snakebites per week and an incidence of 8.84 cases per 100,000 habitants \[[@B2-toxins-09-00342]\]. Approximately 94.6% of the snakebites are caused by snakes of the genus *Bothrops* \[[@B2-toxins-09-00342]\].

In Colombia, *Bothrops asper* is found in the Pacific, Caribbean and Andean (western slopes) regions where it accounts for 50--80% of snakebites \[[@B2-toxins-09-00342]\]. Envenomation by *B. asper* leads to sequelae in 6--10% of cases \[[@B2-toxins-09-00342],[@B3-toxins-09-00342]\], with the most important being the loss of muscle mass leading to limb dysfunction or amputation as a result of myonecrosis, dermonecrosis and severe edema that induces ischemia \[[@B3-toxins-09-00342]\]. The main toxins implicated in these effects are snake venom metalloproteinases (SVMPs) and PLA~2~s \[[@B4-toxins-09-00342],[@B5-toxins-09-00342]\]. Proteomic analyses have shown that *B. asper* venom contains at least seven protein families including disintegrin, phospholipases A~2~, serine proteinases, *C*-type lectins, cysteine-rich secretory proteins (CRISP), *L*-amino acid oxidase, and Zn^2+^-dependent metalloproteinases of which PLA~2~ are an important group \[[@B6-toxins-09-00342]\]. PLA~2~, which hydrolyze phospholipids at the *sn*-2 position to release fatty acids and form lysophospholipids \[[@B7-toxins-09-00342]\], can cause myotoxicity, edema, neurotoxicity, cardiotoxicity and hemolysis, in addition to affecting coagulation, platelet aggregation and showing antibacterial activity \[[@B8-toxins-09-00342]\].

Based on the amino acid sequence and pattern of disulfide bonds, snake venom PLA~2~ have been classified in two groups: Group I PLA~2~ found in venoms of the Elapidae and Hydrophidae and Group II PLA~2~ present in the family Viperidae \[[@B9-toxins-09-00342]\]. PLA~2~s of the latter group are divided into two subgroups: Asp49 PLA~2~s that include catalytically active isoforms and Lys49 PLA~2~s devoid of enzymatic activity \[[@B4-toxins-09-00342]\]. Asp49 PLA~2~s display a wide range of isoelectric points, from acidic to basic, with the acidic isoforms usually having greater catalytic activity but less toxicity than basic PLA~2~s \[[@B10-toxins-09-00342],[@B11-toxins-09-00342]\]. Snake venom acidic PLA~2~s have not been studied as extensively as other PLA~2~s and many of those that have been characterized have been described as non-myotoxic and are involved in pharmacological effects such as hypotension and the inhibition of platelet aggregation \[[@B12-toxins-09-00342]\]. In this paper, we describe the isolation and characterization of a myotoxic acidic PLA~2~ (BaCol PLA~2~) from *B. asper* venom.

2. Results {#sec2-toxins-09-00342}
==========

2.1. Isolation, Determination of Molecular Mass, Sequencing and Modeling of BaCol PLA~2~ {#sec2dot1-toxins-09-00342}
----------------------------------------------------------------------------------------

Fractionation of *B. asper* venom by RP-HPLC resulted in 16 major peaks ([Figure 1](#toxins-09-00342-f001){ref-type="fig"}A) that were collected and screened for PLA~2~ activity. Peak 6 (retention time: 67.48 min) showed high PLA~2~ activity. Analytical chromatography of this peak by RP-HPLC resulted in a single symmetric peak. SDS-PAGE of the purified protein under reducing conditions showed a single band migrating at \~14.5 kDa ([Figure 1](#toxins-09-00342-f001){ref-type="fig"}B) with an isoelectric point (pI) of 4.4 based on isoelectric focusing ([Figure 1](#toxins-09-00342-f001){ref-type="fig"}C). The molecular mass obtained by ESI-Q-ToF was 14,180.69 Da ([Figure 2](#toxins-09-00342-f002){ref-type="fig"}A,B). This protein was named BaCol PLA~2~.

The first 25 amino acids of the *N*-terminal region were determined by Edman degradation. This sequence was used to design the primers to obtain the corresponding cDNA from *B. asper* venom gland mRNA. The cDNA encoded a polypeptide 124 amino acids long ([Figure 3](#toxins-09-00342-f003){ref-type="fig"}), with the presence of Asp at position 49 of the catalytic dyad (based on the numbering of Renetseder et al. \[[@B13-toxins-09-00342]\]) and a theoretical pI of 4.5. The *N*-terminal sequence obtained by Edman degradation was identical to that deduced from cDNA ([Figure 3](#toxins-09-00342-f003){ref-type="fig"}). The DNA sequence was deposited under accession number MF319968.

Alignment of the amino acid sequence with other PLA~2~s is shown in [Figure 4](#toxins-09-00342-f004){ref-type="fig"}. There was a high percentage of identity with a Costa Rican *B. asper* PLA~2~ (BaPLA~2~-II; 91%) and with a PLA~2~ from *B. jararaca* (BJPLA~2~; 83%), both of which have 124 amino acids. There was 81% identity with BinTX-I, a 138-amino acid (including signal peptide) PLA~2~ from *B. insularis*, and BpirPLA~2~-I, a 122-amino acid PLA~2~ from *B. pirajai*. Lower identity was observed with PLA~2~ from *B. jararacussu* (Bth-A-I-PLA~2~), *B. moojeni* (Bmoo-PLA~2~) and *B. alternatus* (Balt1) (78%, 77% and 74%, respectively), all of which are acidic PLA~2~.

After National Center for Biotechnology Information Basic Local Alignment Search Tool (NCBI BLAST) the chain *X* of PLA~2~ from *Bothrops jararacussu* (PDB ID: 1UMV_X) was chosen as template for our homology modeling process. The template has a resolution of 1.79 Å, an identity score of 78%, an *E* value of 7 × 10^−67^ and coverage of 100% with BaCol PLA~2~. Protein modeling yielded a 3D-structure with the general characteristics of venom PLA~2~s, i.e., a calcium-binding loop, two antiparallel helixes, a *β*-wing and a *C*-terminal loop ([Figure 5](#toxins-09-00342-f005){ref-type="fig"}, [Supplementary Materials Figure S1](#app1-toxins-09-00342){ref-type="app"}). The reliability and quality of the structural model was assessed by Procheck. The detailed residue-by-residue stereochemical quality of the BaCol PLA~2~ model was found to be good 91.5% in the most favored regions, 7.5% in additional allowed regions, 1% in generously allowed regions (Arg14) and 0% in disallowed regions ([Supplementary Materials Figure S2](#app1-toxins-09-00342){ref-type="app"}).

The Verify 3D program was used to determine the compatibility of an atomic model (3D) with its own amino acid sequence (1D). This software considers a good score when at least 80% of the amino acids score ≥0.2 in the 3D/1D profile; for BaCol PLA~2~, this value was 87.1%, with scores ranging from 0.05 to 0.53 ([Supplementary Materials Figure S3 and Table S1](#app1-toxins-09-00342){ref-type="app"}). The energetic architecture of the protein folds was determined with the program ProSA and yielded a *Z*-score of −5.2, which is within the range of native conformations for the template (−4.49) (data not shown). The energy profile of the BaCol PLA~2~ predicted model was thus found to be good ([Supplementary Materials Figure S4](#app1-toxins-09-00342){ref-type="app"}).

2.2. Biological Activities {#sec2dot2-toxins-09-00342}
--------------------------

The mean of clot formation time in plasma incubated with BaCol PLA~2~ was 446 ± 31 s, while plasma incubated with PBS (control) clotted after 208 ± 30 s (*n* = 4 each; *p* = 0.0007) The indirect hemolytic activity ([Figure 6](#toxins-09-00342-f006){ref-type="fig"}A) and cleavage of the synthetic substrate 4-nitro-3-octanoyloxy-benzoic acid (4-NOBA) ([Figure 6](#toxins-09-00342-f006){ref-type="fig"}B) by BaCol PLA~2~ was equal to the complete venom using 15 µg/µL of purified toxin that generated a 26 mm halo and 15 µg/µL of complete venom that caused a 20 mm halo; the same cleavage capacity of 4-NOBA was also evidenced for both. BaCol PLA~2~ caused mouse footpad edema, with 5 µg and 20 µg increasing the paw thickness by 45 ± 0.17% and 60 ± 0.11%, respectively, 1 h after toxin inoculation. Maximum edema was observed after 2 h ([Figure 6](#toxins-09-00342-f006){ref-type="fig"}C; *p* \< 0.0001 compared to the control).

BaCol PLA~2~ induced moderate myonecrosis, seen as an increase in plasma creatine kinase (CK) activity 3 h after toxin injection (50 µg/mouse) compared to the control group ([Figure 7](#toxins-09-00342-f007){ref-type="fig"}A). Histopathological analysis confirmed the occurrence of tissue damage ([Figure 7](#toxins-09-00342-f007){ref-type="fig"}B). Compared to control muscle ([Figure 7](#toxins-09-00342-f007){ref-type="fig"}C) where discrete infiltration of neutrophils, mild vascular congestion and absence of necrosis was observed, BACol PLA~2~ caused severe, diffuse muscle fiber damage with vacuolization and necrosis of the sarcoplasm ([Figure 7](#toxins-09-00342-f007){ref-type="fig"}D).

Incubation of U937 cells with BaCol PLA~2~ (1.6 µg/µL) resulted in extensive (82%) damage to the cytoplasmic membrane, seen as high intensity fluorescence for PI ([Figure 8](#toxins-09-00342-f008){ref-type="fig"}B,C). The corresponding damage in control cells was 15% ([Figure 8](#toxins-09-00342-f008){ref-type="fig"}A,C), with most of them showing high intensity fluorescence for DIOC~6~ and negative fluorescence for PI, indicating that they were still viable. At a BaCol PLA~2~ concentration of 0.16 µg/µL, the plasma membrane damage was \~22% ([Figure 8](#toxins-09-00342-f008){ref-type="fig"}D,F); at this concentration, staining with a phytoerythrin-annexin V conjugate detected no phosphatidylserine externalization, indicating there was no early apoptosis. This finding suggested that the mechanism of cell death caused by BaCol PLA~2~ was more compatible with necrosis ([Figure 8](#toxins-09-00342-f008){ref-type="fig"}D). [Figure 8](#toxins-09-00342-f008){ref-type="fig"}E shows the annexin V control without BaCol PLA~2~.

3. Discussion {#sec3-toxins-09-00342}
=============

Many acidic PLA~2~ isolated from snake venoms are devoid of pharmacological activities or toxicity, including myotoxicity \[[@B11-toxins-09-00342],[@B14-toxins-09-00342],[@B15-toxins-09-00342]\]. In this report, we describe the structural and functional characteristics of BaCol PLA~2~, a new acidic myotoxic Asp49 PLA~2~ isolated from Colombian *B. asper* venom. The toxin was obtained in a single chromatographic step by RP-HPLC and had a molecular mass of 14,180.69 Da and pI of 4.4. The complete sequence obtained from *B. asper* venom gland cDNA indicated that this protein differed from other acidic PLA~2~ previously reported for this species \[[@B11-toxins-09-00342]\]. BaCol PLA~2~ contained Asp at position 48 (position 49 is the catalytic diad, according to the numbering of Renetseder et al. \[[@B13-toxins-09-00342]\]), and was therefore classified as an Asp49 PLA~2~. We used homology modeling to obtain a hypothetical 3D structure of BaCol PLA~2~. The model obtained was reliable since the stereochemical quality, the compatibility of the 3D structure with the amino acid sequence and the energy profile of the generated model were similar of those described for other acidic PLA~2~s \[[@B14-toxins-09-00342]\]. In addition, our model showed the conserved residues involved in calcium binding (Tyr28, Gly30, Gly32, His48 and Asp49) and in the catalytic network (His48, Asp99, Tyr52, and Tyr73) \[[@B13-toxins-09-00342]\]. In common with other snake venom acidic PLA~2~ \[[@B7-toxins-09-00342],[@B12-toxins-09-00342]\], BaCol PLA~2~ had highly conserved amino acids, such as 14 cysteines involved in the formation of seven disulfide bonds.

BaCol PLA~2~ was myotoxic, as shown by an increase in circulating creatine kinase and histological damage (involving fiber contraction, clumping and degeneration) to gastrocnemius muscle fibers. However, myotoxicity is not a consistent characteristic of acidic PLA~2~ isolated from *Bothrops* venoms. Thus, whereas acidic PLA~2~ such as BinTX-I from *B. insularis* \[[@B12-toxins-09-00342]\], Bp-PLA~2~ from *B. pauloensis* \[[@B16-toxins-09-00342]\] and BmooTX-I from *B. moojeni* \[[@B17-toxins-09-00342]\] venoms are myotoxic, others, such as PLA~2~s from *B. jararaca* \[[@B18-toxins-09-00342]\], Costa Rican *B. asper* \[[@B11-toxins-09-00342]\], *B. pirajai* \[[@B14-toxins-09-00342]\] and *B. moojeni* \[[@B19-toxins-09-00342]\] are not. BaCol PLA~2~ showed high identity (91%) with Costa Rican BaspPLA~2~-II; the incomplete identity suggests that variations in some amino acid residues could play an important role in determining the occurrence of myonecrosis.

Similar results were found with BmooTX-I obtained from *B. moojeni*, in which extensive cellular destruction and abundant leukocitary infiltrate were described and, further displaying contracted and clumped fibers in different stages of degeneration \[[@B17-toxins-09-00342]\]. Bp-PLA~2~ from *B. pauloensis* \[[@B16-toxins-09-00342]\], whose myotoxicity was confirmed by the increase in the CK activity was similar to induced by whole venom. In the same way, BinTX-I from *B. insularis*, also increased CK activity. Nevertheless, morphological analysis, showed BinTX-I produced less damaged proportion of fibers than the venom \[[@B12-toxins-09-00342]\].

BaCol PLA~2~ was highly edematogenic, with the peak response occurring 2 h after toxin injection. This finding agrees with other acidic PLA~2~ with which BaCol PLA~2~ shares considerable identity \[[@B10-toxins-09-00342],[@B11-toxins-09-00342],[@B12-toxins-09-00342],[@B14-toxins-09-00342],[@B19-toxins-09-00342]\].

BaCol PLA~2~ was cytotoxic to U937 lymphocytes at concentrations ranging from 0.016 µg/µL (data not shown) to 1.6 µg/µL after 24 h. Santos Filho et al. \[[@B17-toxins-09-00342]\] reported that BmooTX-I was able to hydrolyze cell membrane phosphatidylcholine to release free fatty acids and lysophospholipids, resulting in cellular damage. In contrast, Bl-PLA~2~ from *Bothrops leucurus* did not affect the viability of human peripheral blood mononuclear cells \[[@B20-toxins-09-00342]\]. Similarly, BaspPLA~2~-II did not damage the cell membrane of C2C12 skeletal muscle myoblasts in culture \[[@B11-toxins-09-00342]\]. Staining of U937 lymphocytes with annexin V and PI revealed no early apoptosis (no exposure of phosphatidylserine), indicating that cell death was by necrosis rather than apoptosis. Mora et al. \[[@B21-toxins-09-00342]\] reported that a basic Lys49 PLA~2~ from Costa Rican *B. asper* induced apoptosis at concentrations of 5--25 µg/mL, whereas necrosis was observed at a concentration of 50 µg/mL. In contrast, our findings revealed no marked differences in the effects seen with two concentrations of BaCol PLA~2~ (0.16 μg/μL and 1.6 µg/μL).

BaCol PLA~2~ showed anticoagulant activity based on prolongation of the plasma clotting time. Anticoagulant activity has not generally been evaluated among other acidic PLA~2~, except for BaPLA~2~-II, which was found to have no such activity \[[@B11-toxins-09-00342]\]. Compared to the strong anticoagulant activity of basic PLA~2~s, that of BaCol PLA~2~ was quite weak. This discrepancy could be explained by the finding that in PLA~2~s with high anticoagulant activity the putative anticoagulant site located between residues 54 and 77 is positively charged, contrary to PLA~2~ with moderate or low anticoagulant activity, in which there is a predominance of negative or neutral charges in this region \[[@B22-toxins-09-00342]\]. This explanation based on structure agrees with the presence of four aspartic acid and two glutamic acid in this segment in the amino acid sequence of BaCol PLA~2~. In [Table 1](#toxins-09-00342-t001){ref-type="table"} can be observed the comparative characteristics of BaCol PLA~2~ and other acidic PLA~2~ describe before.

In Colombia there are few studies for *B. asper* acidic myotoxic PLA~2~ and therefore it is necessary to deepen in order to understand better its action mechanism and its relationship with the effects induced by venom.

4. Materials and Methods {#sec4-toxins-09-00342}
========================

4.1. Venom {#sec4dot1-toxins-09-00342}
----------

*Bothrops asper* venom from central Magdalena in Antioquia was donated by the Antioquia University serpentarium. The pool of venom was obtained by manual milking of 30 adult specimens. The venom was centrifuged, lyophilized and frozen at −70 °C until used.

4.2. Animals {#sec4dot2-toxins-09-00342}
------------

Male Swiss-Webster mice were supplied by the Animal House (Sede de Investigacion Universitaria--SIU) of the Universidad de Antioquia and maintained under standard conditions with access to food and water *ad libitum*. The experimental protocol was approved by the institutional Committee for the Use and Care of Research Animals at the Universidad de Antioquia (license nos. 70 (2011) and 102 (2016)).

4.3. Isolation of BaCol PLA~2~ {#sec4dot3-toxins-09-00342}
------------------------------

Venom (10 mg) was dissolved in 200 µL of 0.1% trifluoroacetic acid (TFA; solvent A), centrifugated and applied to a reverse-phase high performance liquid chromatography (RP-HPLC) C18 semipreparative column (250 × 10 mm, 5 μm particle; Restek, Bellefonte, PA, USA), using a Shimadzu Prominence-20A chromatograph. Elution was performed at 2 mL/min by applying solution B (acetonitrile, containing 0.1% TFA) as follows: 5% B for 5 min, 15% B over 15 min, 45% over 75 min, 70% B over 85 min, 90 min 70%. The elution profile was monitored at 215 nm in a UV/VIS photodiode array detector (Shimadzu, Kyoto, Japan). The peaks were collected and evaluated by SDS PAGE on a 12% polyacrylamide gel and peaks with electrophoretic bands of \~15 kDa were subsequently screened for hemolytic activity. Of the peaks obtained, only two had hemolysis halo greater than 20 mm, but only one was located around 15 kDa and that is the reason to choose it. The enzymatically active fraction was subsequently applied to a liquid chromatography (RP-HPLC) C18 analytical column (250 × 4.6 mm; Restek, Bellefonte, PA, USA), using a Shimadzu Prominence-20A chromatograph. Elution was performed at 1 mL/min by applying solution B (acetonitrile, containing 0.1% TFA) as follows: 0% B for 0 min, 100% B over 30 min. The elution profile was monitored at 215 nm in a UV/VIS photodiode array detector (Shimadzu, Kyoto, Japan).

The electrophoretic homogeneity of BaCol PLA~2~ was evaluated by SDS-PAGE. For this, 20 µg of protein was loaded onto a 12% polyacrylamide gel and run in a Mini-Protean Tetra^®^ electrophoresis system (Bio-Rad, Hercules, CA, USA) at 150 V. The gel was subsequently stained with Coomassie blue *R*-250 \[[@B23-toxins-09-00342]\].

4.4. Molecular Mass and N-Terminal Determination {#sec4dot4-toxins-09-00342}
------------------------------------------------

Protein purity and molecular mass were also examined by ESI-Q-ToF mass spectrometry using a MicrQ-TOF III mass spectrometer (Bruker Daltonics, Billerica, MA, USA) coupled to an LC-20AT liquid chromatograph (Shimadzu, Kyoto, Japan). Two mobile phases were used: water (A) and acetonitrile (B), both in the presence of 0.1% (*v*/*v*) formic acid. Chromatographic runs were done on a C18 reverse-phase column (4.5 mm × 100 mm, 1.8 μm). The elution conditions were consisted of a 0--85% linear gradient of solvent B for 60 min at a flow rate of 0.2 mL/min. The sample column and automatic applicator were held at 25 °C and 10 °C, respectively. The mass spectrometer was operated at 4.5 kV with a solvation temperature of 180 °C, positive mode with an ionization interval between 100 m/z and 3000 m/z, a nitrogen flow of 6 L/min and pressure of 0.8 bars. The data were processed using Bruker Data Analysis software (version 3.3, Billerica, MA, USA, 2011).

The *N*-terminal sequence was determined using a Shimadzu automatic protein sequencer (PPSQ-23A model). An aliquot of the sample (\~1 mg/mL) was applied to the sequencer and the sequence was determined by Edman degradation \[[@B24-toxins-09-00342]\]. The *N*-terminal sequence was subsequently aligned with other snake venom PLA~2~s using BLAST \[[@B25-toxins-09-00342]\] and MultAlin \[[@B26-toxins-09-00342]\] programs.

4.5. cDNA and Nucleotide Sequencing {#sec4dot5-toxins-09-00342}
-----------------------------------

A venomous gland from a dead adult specimen of *B. asper* from the serpentarium of the Universidad de Antioquia was used to obtain the complete sequence of the toxin. The gland total RNA was extracted with QIAzol^®^ according to the manufacturer's instructions (Qiagen, Hilden, Germany). The RNA was subsequently retrotranscribed using Superscript III enzyme (Invitrogen^®^) as recommended by the manufacturer (Invitrogen Corporation, Carlsbad, CA, USA). The mRNA was transformed into cDNA using a dNTP mix and specifically designed *N*-terminal-based primers: external primer 5′-GTTTGGCCAGATGATGAGCG-3′ and internal primer 5′-GGCGATGATCCGTGCAAAAA-3′. The cDNA was cloned into the vector pGEM-*T* Easy (Promega, Madison, WI, USA) and DH5-*α E. coli* were transformed. PCR was used to detect the presence of the vector with the toxin sequence. The plasmid was obtained from these transformed colonies using the construct and a QIA prep^®^ spin miniprep kit (Qiagen, Hilden, Germany). The product of this extraction was sequenced (Macrogen, Seoul, Korea) to certify that it corresponded to whole plasmids with the gene inserted in the multiple cloning site. Sequencing was done from the vector T7 and SP6 promoters. The DNA sequence data were analyzed and translated into the amino acid sequence using Mega 6 software \[[@B27-toxins-09-00342]\]. Protein sequence homology in the Swiss-Prot database was searched using FASTA3 \[[@B28-toxins-09-00342]\] and sequence alignments were generated with CLUSTAL W 2.1. The theoretical isoelectric point was calculated with ExPASy \[[@B29-toxins-09-00342]\].

4.6. Bidimensional Electrophoresis and Determination of Isoelectric Point {#sec4dot6-toxins-09-00342}
-------------------------------------------------------------------------

For the first dimension, 30 µg of BaCol PLA~2~ was applied to a 7 cm long immobilized pH gradients strip (pH 3--10). The strip was rehydrated overnight at room temperature in 125 µL of rehydration solution containing 8 M urea, 2% (*w*/*v*) CHAPS, 1% of immobilized pH gradient (IPG) buffer solution, 19 nM dithiothreitol (DTT) and bromophenol blue. Isoelectric focusing was done in three steps: first step---500 V for 30 min, second step---1000 V for 30 min, and third step---5000 V for 2 h. The strip was subsequently equilibrated for 20 min in 19 mM DTT, 50 mM Tris, 6 M urea, 30% glycerol (*v*/*v*) and 2% SDS (*w*/*v*) followed by a further 20 min in the same solution, except that DTT was replaced by 0.2 M iodioacetamide. For the second dimension, the isoelectric focusing strip was place on top of a 10% polyacrylamide gel (10 × 10 cm, 1.5 mm thick). Electrophoresis was done at room temperature in two steps (10 mA per gel for 15 min and then 20 mA per gel for 1 h) and the gel then stained with Coomassie Brilliant Blue. The biodimensional gel was digitized using an ImageScanner III scanner (GE Healthcare Life Sciences, Issaquah, WA, USA) in transmission mode and the image was analyzed using Image Master 2D Platinum v 7.05 (GE Healthcare, Little Chalfont, UK) software to determine the isoelectric point.

4.7. Molecular Modeling {#sec4dot7-toxins-09-00342}
-----------------------

The NCBI Basic Local Alignment Search Tool (BLAST) for sequence similarities was used to search the crystal structures of the closest homologs available in the Brookhaven Protein Data Bank (PDB). The results retrieved by NCBI BLAST identified chain *X* of PLA~2~ from *Bothrops jararacussu* (PDB ID: 1WMV_X) with a resolution of 1.79 Å as a suitable template with an identity score of 78%, an E value of 7 × 10^−67^ and coverage of 100%. The three-dimensional model of BaCol PLA~2~s was obtained using the program Modeller (9.17) \[[@B30-toxins-09-00342],[@B31-toxins-09-00342]\]. This program is completely automated and capable of generating energy minimized protein models by satisfying spatial restraints on bond distances and dihedral angles extracted from the template PDB file. Modeller performs automatic loop modeling and model optimization. Numerous runs of Modeller were used to generate the most plausible model. The stereochemical excellence of the protein structure and overall structural geometry were confirmed using Procheck \[[@B32-toxins-09-00342]\]. The energy of residues was checked with ProSA using the web service ProSA-web \[[@B33-toxins-09-00342],[@B34-toxins-09-00342]\]. Verify 3D software was used to determine the compatibility of an atomic model (3D) with its own amino acid sequence (1D) by assigning a structural class based on its location and environment (*α*, *β*, loop, polar, non-polar, etc.), as well as by comparing the results with good database structures \[[@B35-toxins-09-00342]\].

4.8. PLA~2~ Activity {#sec4dot8-toxins-09-00342}
--------------------

PLA~2~ activity was evaluated in vitro by indirect hemolysis on agar gel containing human erythrocytes and egg yolk \[[@B36-toxins-09-00342]\] and by cleavage of the synthetic substrate 4-NOBA \[[@B37-toxins-09-00342],[@B38-toxins-09-00342]\], the latter modified for 96-well plates. For the latter assay, the standard assay mixture contained 200 μL of buffer (10 mM Tris-HCl, 10 mM CaCl~2~, 100 mM NaCl, pH 8.0), 20 μL of 4-NOBA, 20 μL of water and 20 μL of PLA~2~ (1 μg/μL) in a final volume of 260 μL. After adding BaCol PLA~2~ (20 μg), the mixture was incubated at 37 °C for 60 min after which the absorbance was determined at 405 nm using a multi-well plate reader (Awareness, Stat Fax 3200, Westport, CT, USA). The activity was expressed as the increase in absorbance/min during the linear phase of the reaction. All the assays were done in triplicate. *Bothrops asper* venom and synthetic substrate 4-NOBA without toxin were used as positive and negative controls, respectively.

4.9. Edematogenic Activity {#sec4dot9-toxins-09-00342}
--------------------------

BaCol PLA~2~ (5 μg and 20 μg) diluted in 50 μL of phosphate-buffered saline (PBS) was injected subcutaneously in the right hind paw footpad and control mice were injected with 50 μL of PBS (*n* = 4 mice/group, experiment was performed in duplicate). Footpad thickness was measured (in mm) with calipers 1, 2 and 3 h after toxin injection. Hind paw footpad thickness was measured prior to the inoculations and edema was expressed as the increase of this measure in each of the three moments with respect to the initial measurement \[[@B39-toxins-09-00342]\].

4.10. Myotoxicity {#sec4dot10-toxins-09-00342}
-----------------

Mice were inoculated in the right gastrocnemius muscle with 0.9% NaCl (100 µL; control; *n* = 4) or BaCol PLA~2~ (50 µg in 100 µL of 0.9% NaCl; *n* = 4). After 3 h, a 70 µL blood sample was collected from the tail vein into heparinized capillaries. The plasma was separated and used to quantify CK activity (CK-NAC UV, Wiener Lab^®^, Rosario, Argentina) according to the manufacturer's instructions, with the final absorbance being measured at 280 nm \[[@B40-toxins-09-00342],[@B41-toxins-09-00342]\]. The gastrocnemius muscle was dissected and fragments were processed for histopathological analysis. Sections 4 µm thick were stained with hematoxylin and eosin and examined for myonecrosis, edema, congestion and leukocyte infiltrate. The extent of myonecrosis was calculated by examining 3 non-overlapping regions in each cross-sections/muscle or mouse (4 mice/group) as the percentage of the examined area corresponding to necrotic fibers, (myofibril disorganization, delta lesions, vacuolation).

4.11. Anticoagulant Activity {#sec4dot11-toxins-09-00342}
----------------------------

The effect of BaCol PLA~2~ on the clotting time of human plasma was examined by preincubating 20 μg of enzyme (in 50 μL of PBS) with 500 μL of human citrated plasma for 10 min at 37 °C, in duplicate. Subsequently, 100 μL of 0.25 M CaCl~2~ was added and time to clot (in seconds) was recorded manually. Plasma aliquots preincubated with PBS were used as controls \[[@B36-toxins-09-00342]\]. The assay was performed in triplicate.

4.12. Cell Viability and Cell Death {#sec4dot12-toxins-09-00342}
-----------------------------------

U937 cells were used to assess alterations on the mitochondrial permeability transition (MPT) and damage to the cell membrane. The cells were suspended in RPMI 1640 medium supplemented with 10% fetal bovine serum and then plated at a density of 300.000 cells/well (total volume/well: 300 μL) followed by incubation at 37 °C for 24 h. DIOC~6~ and propidium iodide (PI) were used to determine the MPT and cell membrane damage, respectively, by flow cytometry (FACSCanto II). BaCol PLA~2~ cytotoxicity was evaluated at concentrations ranging from 0.016 μg/μL to 1.6 μg/μL after 24 h. The cells that showed high intensity fluorescence for DIOC~6~ and negative fluorescence for PI were classified as viable, whereas those with high intensity fluorescence for PI were considered to be dead (as a consequence of damage to the cytoplasmic membrane). To determine the type of cell death induced by PLA~2~, cells were suspended in medium containing PI and annexin V (Invitrogen^®^, Carlsbad, CA, USA). Cells were considered apoptotic when they showed positive staining for annexin V and negative staining for PI; non-apoptotic cells showed no staining for either dye. Cells in the early stages of apoptosis were positive for annexin V and negative for PI, whereas necrotic cells showed double-positive staining. Cells suspended in RPMI 1640 and stains without PLA~2~, were used as negative controls in both experiments.

4.13. Statistical Analysis {#sec4dot13-toxins-09-00342}
--------------------------

Numerical data were expressed as the mean ± SD. Statistical comparisons were done using Student's *t*-test or one-way ANOVA followed by the Bonferroni test, with *p* \< 0.05 indicating significance. All data analyses were done using the software GraphPad Prism 5.01 version for Windows (GraphPad Software, San Diego, CA, USA, 2007).
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![Isolation of BaCol PLA~2~ (acidic Asp49 phospholipases A~2~). (**A**) Elution profile of *B. asper* venom by RP-HPLC (reverse-phase high performance liquid chromatography) on a Resteck C18 semi-preparative column. The fraction indicated by the arrow showed high PLA~2~ activity; (**B**) The PLA~2~ fraction was analyzed by RP-HPLC and purity was assessed by SDS-PAGE on a 12% polyacrylamide gel in reducing conditions. MM--molecular mass markers (in kDa); (**C**) Isoelectric focusing in a 10% polyacrylamide gel (pI range: 3--10). MM: molecular mass markers (in kDa).](toxins-09-00342-g001){#toxins-09-00342-f001}

![Mass spectrometric analysis of BaCol PLA~2~. (**A**) Spectrum obtained in multi-charge mode, as described in Materials and Methods; the inset (**B**) shows the deconvolution of the multi-charged ion series indicated in (**A**).](toxins-09-00342-g002){#toxins-09-00342-f002}

![cDNA and translated amino acid sequence of BaCol PLA~2~. The *N*-terminal sequence (first 25 amino acids) determined by direct Edman degradation is underlined.](toxins-09-00342-g003){#toxins-09-00342-f003}

![Multiple sequence alignment of BaCol PLA~2~ with other PLA~2~ isolated from *Bothrops* snake venoms. Protein access codes are indicated in the first column. The number of amino acids, percentage identity compared to BaCol PLA~2~ and the species of origin are also indicated. Cysteine residues are highlighted in dark gray and amino acid sequence variants in light gray. The loop for calcium residues are highlighted in red. The residues of the active site are indicated with blue boxes. The residues of the putative site for anti-clotting activity are underlined with orange.](toxins-09-00342-g004){#toxins-09-00342-f004}

![Three-dimensional model of BaCol PLA~2~. The active site residues (Asp and His) of the enzyme are shown in sticks and Ca^2+^ is shown as a light green sphere.](toxins-09-00342-g005){#toxins-09-00342-f005}

![BaCol PLA~2~ activity and edema formation. (**A**) Indirect hemolytic activity of BaCol PLA~2~ (15 µg/µL) and venom (15 µg/µL) assayed using human erythrocytes and egg yolk as substrate. Activity was expressed as the diameter of the hemolytic halo after incubation for 20 h at 37 °C (**B**) Hydrolysis of the synthetic substrate 4-nitro-3-octanoyloxy-benzoic acid by BaCol PLA~2~ (1 µg/µL) and venom (1 µg/µL), measured as the increase in absorbance after incubation for 1 h at 37 °C; (**C**) Mouse hind paw edema induced by BaCol PLA~2~. PBS (50 µL) (white circles) or BaCol PLA~2~ (5 µg---gray circles or 20 µg---black circles) in 50 µL of PBS was injected into the hind footpad of male Swiss-Webster mice and edema formation was monitored as the increase in footpad thickness for up to 3 h, using calipers. The columns and points are the mean ± SD *n* = 3 (panels **A** and **B**) and 4 in (panel **C**); \* *p* \< 0.05 compared to PBS or the corresponding control; \*\*\* *p* \< 0.001 compares to PBS or the corresponding control.](toxins-09-00342-g006){#toxins-09-00342-f006}

![Myonecrosis caused by BaCol PLA~2~ in mouse gastrocnemius muscle. (**A**) Plasma CK activity 3 h after injection of BaCol PLA~2~ (50 µg/100 µL, i.m.) compared to mice injected i.m. with 0.9% NaCl (control); (**B**) Percentage of necrosis determined as described in the Methods; (**C**,**D**) Histology of gastrocnemius muscle injected with 0.9% NaCl (control) and BaCol PLA~2~, respectively. Hematoxylin and Eosin staining. The columns in (**A**,**B**) are the mean ± SD (*n* = 4); \* *p* \< 0.05 compared to control mice. The white bar represents 10 microns.](toxins-09-00342-g007){#toxins-09-00342-f007}

![Cytotoxicity of BaCol PLA~2~ in U937 lymphocytes. (**A**) Normal cells not incubated with BaCol PLA~2~ (viability: 85%); (**B**) Cells incubated with BaCol PLA~2~ (1.6 µg/µL) (membrane damage: 82%); (**C**) Cell membrane damage (%) induced by BaCol PLA~2~ compared to control (non-treated) cells. The columns are the mean ± SD (*n* = 3); (**D**) Cell membrane damage induced by BaCol PLA~2~ (0.16 µg/µL); (**E**) Negative control for annexin V conjugated with phycoerythrin; (**F**) Cells incubated with BaCol PLA~2~ (0.16 µg/µL). There was no phosphatidylserine exposure indicative of early apoptosis. \* *p* \< 0.05 compared to control cells.](toxins-09-00342-g008){#toxins-09-00342-f008}

toxins-09-00342-t001_Table 1

###### 

Comparative characteristics between BaCol PLA~2~ and other acidic PLA~2~s.

  Reference                     Phospholipase    Isoelectric Point   Myotoxic Activity   Edematogenic Activity   Platelet Aggregation   Anti-Clotting Activity
  ----------------------------- ---------------- ------------------- ------------------- ----------------------- ---------------------- ------------------------
  Posada et al, 2017            BaCol PLA~2~     4.4                 Yes                 Yes                     \-                     Moderate
  Cogo et al., 2006             BinTx-I          5.05                Yes                 Yes                     \-                     \-
  Rodrigues et al., 2007        Bp-PLA~2~        4.3                 Yes                 Yes                     Inhibits               \-
  Santos et al., 2008           BmooTx-I         4.2                 Yes                 Yes                     Inhibits               \-
  Fernandez et al., 2010        Basp PLA~2~-II   4.9                 No                  Yes                     Does not inhibit       No
  Teixeira et al., 2011         Bpir PLA~2~-I    4.8                 No                  Yes                     Inhibits               \-
  Silveira et al., 2013         Bmoo PLA~2~      5.2                 No                  Yes                     Inhibits               Yes
  AndriaoEscarso et al., 2002   BthA-I-PLA~2~    4.5                 No                  Yes                     Inhibits               Low
  Nunes et al., 2011            Bl PLA~2~        5.4                 Low                 Low                     \-                     \-
  Serrano et al., 1999          BJ PLA~2~        \-                  \-                  No                      Inhibits               \-
